GS Gmbh to integrate Masimo Rainbow SET Pulse CO-Oximetry into corpuls patient monitoring modules

Aug 20 2009

Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, and GS Elektromedizinische Gerate G. Stemple GmbH, a German developer and manufacturer of innovative medical equipment for the Emergency Medical Services (EMS), today jointly announced a worldwide technology licensing agreement to integrate Masimo Rainbow SET Pulse CO-Oximetry into corpuls(R) patient monitoring modules. The agreement enables GS GmbH to expand the vital signs and noninvasive measurement capabilities of its defibrillators and patient monitoring systems to help EMS professionals detect and treat life-threatening conditions earlier.

The breakthrough noninvasive blood constituent monitoring capabilities of Masimo Rainbow SET Pulse CO-Oximetry allow for continuous monitoring of hemoglobin, carbon monoxide, methemoglobin, PVI for fluid responsiveness, perfusion index, and measure-through motion pulse oximetry. With Masimo Rainbow SET, the ability to detect internal bleeding, carbon monoxide poisoning, methemoglobinemia, fluid responsiveness, perfusion, saturation, and pulse rate quickly, easily and continuously can help save lives and improve patient outcomes.

According to Klaus Stemple, General Manager of GS GmbH, the key to "developing better lifesaving support solutions and techniques is to stay ahead of the mainstream. Our corpuls products are innovative leaders in the defibrillator market and the integration of Masimo Rainbow SET Pulse CO-Oximetry measurements is another consistent step in the design and manufacture state-of-the-art defibrillator/monitoring-systems that spearhead the industry in patient monitoring performance. The combination of corpuls and Masimo Rainbow SET creates a unique defibrillator solution for EMS professionals looking to leverage additional vital parameters to more thoroughly assess a patient's physiological status and make better clinical and treatment decisions."

The corpuls3--a unique 3-in-1 modular defibrillator system combining three components including: a compact patient box, a large monitoring unit, and a defibrillator/pacer unit -- will be one of the first products to feature Masimo Rainbow SET Pulse CO-Oximetry capabilities. The Masimo Rainbow SET measurement option will be available in mid-2010.

Masimo Founder and CEO, Joe E. Kiani, stated, "GS GmbH was one of the first European equipment manufacturers to license Masimo SET pulse oximetry technology over 10 years ago. Today, they are still a market leader in providing innovative EMS solutions throughout Europe and, with this technology license agreement, will further expand the availability of Masimo Rainbow SET Pulse CO-Oximetry to the benefit of patients and EMS professionals alike."

www.masimo.com